lixivaptan has been researched along with way-151932 in 1 studies
| Studies (lixivaptan) | Trials (lixivaptan) | Recent Studies (post-2010) (lixivaptan) | Studies (way-151932) | Trials (way-151932) | Recent Studies (post-2010) (way-151932) |
|---|---|---|---|---|---|
| 80 | 10 | 26 | 6 | 0 | 1 |
| Protein | Taxonomy | lixivaptan (IC50) | way-151932 (IC50) |
|---|---|---|---|
| Vasopressin V2 receptor | Homo sapiens (human) | 0.0802 | |
| Oxytocin receptor | Homo sapiens (human) | 0.353 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.08 | |
| Vasopressin V1a receptor | Homo sapiens (human) | 1.072 | |
| Oxytocin receptor | Rattus norvegicus (Norway rat) | 0.055 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, K; Bagli, J; Cochran, D; Considine, J; Croce, S; Demaio, W; Lihotz, L; Molinari, AJ; Qi, J; Trybulski, EJ | 1 |
1 other study(ies) available for lixivaptan and way-151932
| Article | Year |
|---|---|
Identification and synthesis of major metabolites of Vasopressin V2-receptor agonist WAY-151932, and antagonist, Lixivaptan.
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Humans; In Vitro Techniques; Pyrroles; Receptors, Vasopressin | 2007 |